AsemconnectVietnam - Central Pharmaceutical JSC N.3 (DP3 - HNX) said that on March 24, it will close the list of shareholders attending the 2025 Annual General Meeting of Shareholders and pay interim dividends for 2024.

Accordingly, the Company will hold the meeting on the morning of April 25, at the Company Hall, No. 472, Street 351, Quynh Hoang Residential Group, Nam Son Ward, An Duong District, Hai Phong City. The meeting content will be announced specifically by the Company later.
At the same time, Central Pharmaceutical 3 will pay cash dividends at a rate of 30%, corresponding to shareholders owning 1 share will receive VND3,000. The ex-dividend date is March 21, the expected dividend payment date is July 8.
With approximately 21.5 million listed and outstanding shares, the Company will have to spend about VND64.5 billion to pay dividends to existing shareholders. Thus, the actual dividend payment has exceeded the previously set plan of 20% in cash.
The above developments are consistent with the positive business results of the enterprise. Specifically, at the end of 2024, Central Pharmaceutical 3 recorded revenue of VND422.6 billion, a slight increase compared to the previous year; while pre-tax and after-tax profits decreased slightly, reaching approximately VND 152 billion and VND121.2 billion, respectively.
Compared to the set plan of VND420 billion in revenue and VND86 billion in pre-tax profit, in 2024, the Company slightly exceeded the revenue target and exceeded the profit target by 76.74%.
N.Nga
Source: VITIC/Tinnhanhchungkhoan